Nathaniel Robinson, MD
Medical Oncology · Middletown, CTNPI 1235665571
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,720 of the $2,161 with a category attached, or 79.6%. Boehringer Ingelheim accounts for 79.6% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $1,764, 5.9 times the $299 reported in 2021. That places this record below the midpoint for medical oncology clinicians in CT, where the typical reported total is $3,212.
Across 7 payments — averaging $308.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$2K
- Amgen$280
- Incyte Corporation$99
- Galvanize Therapeutics, Inc$44
- Johnson & Johnson$18
Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$500
What the payments were for
- Consulting fees$1,72080%
- Food & beverage$623%
- Education$37918%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 1 | $1,720 |
| Amgen | 3 | $280 |
| Incyte Corporation | 1 | $99 |
| Galvanize Therapeutics, Inc | 1 | $44 |
| Johnson & Johnson | 1 | $18 |
How this compares
$2,161 in reported general payments places this provider in the 45th percentile of 79 medical oncology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Middletown
- Peter MarksNew Haven$578K
- Daniel PetrylakNew Haven$446K
- Mandar MuzumdarNew Haven$371K
- Barbara BurtnessNew Haven$297K
- Ian KropNew Haven$219K
- Joseph McLaughlinManchester$200K
- Francine FossNew Haven$193K
- William OhGreenwich$162K
- Anne ChiangNew Haven$158K
- Mario SznolNew Haven$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.